Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elisabetta Zulato
Observed names:
E Zulato,
E. Zulato,
Zulato, Elisabetta
Institution:
Azienda Ospedale - Università Padova
Observed institutions:
University of Padua,
University Medical Center of the Johannes Gutenberg University Mainz,
Institut Català d'Oncologia,
Istituto Oncologico Veneto,
Azienda Ospedale - Università Padova
ORCID:
0000-0002-2624-5060
Observed ORCID:
0000-0002-2624-5060
OpenAlex ID:
A5019015189
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
2014
·
Anna Pastò
, Chiara Bellio
, et al.
·
Oncotarget
·
299
PDF
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
2019
·
Francesco Ciccarese
, Elisabetta Zulato
, et al.
·
Oxidative Medicine and Cellular Longevity
·
154
PDF
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC
2018
·
Massimo Moro
, Elisa Caiola
, et al.
·
Journal of Thoracic Oncology
·
106
PDF
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
2022
·
Laura Bonanno
, Alessandro Dal Maso
, et al.
·
British Journal of Cancer
·
84
PDF
VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
2014
·
Matteo Curtarello
, Elisabetta Zulato
, et al.
·
Cancer Research
·
76
Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF Neutralization
2011
·
Giorgia Nardo
, Elena Favaro
, et al.
·
Cancer Research
·
76
ALMS1-Deficient Fibroblasts Over-Express Extra-Cellular Matrix Components, Display Cell Cycle Delay and Are Resistant to Apoptosis
2011
·
Elisabetta Zulato
, Francesca Favaretto
, et al.
·
PLoS ONE
·
69
PDF
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer
2019
·
Laura Bonanno
, Elisabetta Zulato
, et al.
·
International Journal of Molecular Sciences
·
55
PDF
LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab
2017
·
Laura Bonanno
, Angela De Paoli
, et al.
·
Clinical Cancer Research
·
53
Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab
2014
·
E Zulato
, F Bergamo
, et al.
·
British Journal of Cancer
·
49
PDF
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome
2021
·
Alberto Pavan
, Andrea Boscolo Bragadin
, et al.
·
Translational Lung Cancer Research
·
48
PDF
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer
2020
·
Elisabetta Zulato
, Ilaria Attili
, et al.
·
British Journal of Cancer
·
48
Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by different growth factors
2017
·
Annalisa Trenti
, Elisabetta Zulato
, et al.
·
British Journal of Pharmacology
·
48
LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation
2018
·
E. Zulato
, F. Ciccarese
, et al.
·
Biochemical Pharmacology
·
43
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy
2019
·
Alessandro Dal Maso
, Martina Lorenzi
, et al.
·
Clinical Lung Cancer
·
27
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
2022
·
Elisabetta Zulato
, Paola Del Bianco
, et al.
·
British Journal of Cancer
·
25
PDF
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer
2024
·
Andrea Boscolo Bragadin
, Paola Del Bianco
, et al.
·
npj Precision Oncology
·
23
PDF
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis
2021
·
Loredana Urso
, Grazia Vernaci
, et al.
·
Frontiers in Oncology
·
23
PDF
Lipoatrophy Induced by Subcutaneous Insulin Infusion: Ultrastructural Analysis and Gene Expression Profiling
2010
·
G. Milan
, I. Murano
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
23
Vandetanib Improves Anti-Tumor Effects of L19mTNFα in Xenograft Models of Esophageal Cancer
2010
·
Marika Crescenzi
, Luca Persano
, et al.
·
Clinical Cancer Research
·
19
PDF
Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients
2021
·
Elisabetta Zulato
, Valeria Tosello
, et al.
·
Diagnostics
·
18
PDF
Metformin: a modulator of bevacizumab activity in cancer? A case report
2015
·
Stefano Indraccolo
, Giovanni Randon
, et al.
·
Cancer Biology & Therapy
·
18
PDF
Metabolic effects of anti-angiogenic therapy in tumors
2012
·
Elisabetta Zulato
, Matteo Curtarello
, et al.
·
Biochimie
·
18
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach
2020
·
Ilaria Piga
, Martina Verza
, et al.
·
Frontiers in Oncology
·
17
PDF
Involvement of NADPH Oxidase 1 in Liver Kinase B1-Mediated Effects on Tumor Angiogenesis and Growth
2018
·
Elisabetta Zulato
, Francesco Ciccarese
, et al.
·
Frontiers in Oncology
·
16
PDF
Show more works
View as search
Works count:
80
Citation count:
1,536
H-index:
19
I10-index:
29
Year
Topic
Type